Skip to content

Contact +44 (0) 20 7060 7474 email us

Biotechnology

Stem Cell Research

Market Trends, Investment Trends and Pipeline Analysis

Publication Date February 2010
Publisher GBI Research
Product Type Report
Pages 77
ISBN Number not applicable
Product Code GBI00028

Price

£2,310.00
approximately: $3,498 | €2,578

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

GBI Research, the leading business intelligence provider, has released its latest research "Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis". It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key trends shaping and driving stem cell research and development. The report analyses investment decisions within the stem cell research market by providing information on pipelines, federal spending, investor perspectives, regulatory environment, competitive landscape and market potential. The study also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning. Most importantly, the report provides valuable insight on the pipeline products within the global stem cell industry.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

  • Unmet needs and opportunity analysis for therapies that are currently in pipeline.
  • Market characterization including market sizing, technology adoption framework and business models for the stem cell market.
  • A cross-country analysis for regulatory framework, investments, research clusters and support including the US (United States), the UK (United Kingdom), Germany, France, Japan, China, India, Singapore, Canada and Australia
  • In-depth information and analysis on the pipeline products expected to bring a shift in the market positions of the leading manufacturers.
  • Analysis and review of the key events and milestones that will impact the future of the global stem cell market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how companies are responding to these trends.
  • Insightful review of key industry drivers, restraints and challenges which are likely to impact the global stem cell research and development in the long run.
  • Information on the leading market players and the prevailing competitive landscape. Key companies covered include Osiris Therapeutics, Aastrom Biosciences, Cytori Therapeutics, Pluristem Therapeutics and Geron.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying companies with the most robust pipelines
  • Develop business strategies by understanding the trends shaping and driving stem cell research and development.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the stem cell market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships
  • What's the next big thing in the stem cell research and development landscape? - Identify, understand and capitalize.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 GBI Research Report Guidance
  • 3 Market Overview
    • 3.1 Stem Cell Research - An Introduction
    • 3.2 Types of Stem Cell Research
    • 3.3 Unmet Needs
    • 3.4 Applications of Stem Cell Research
  • 4 Market Characterization
    • 4.1 Stem Cell Market - An Introduction
    • 4.2 Market Sizing
    • 4.3 Therapy cost
    • 4.4 Technology Adoption Framework
    • 4.5 Types of Business Models
    • 4.6 Market Drivers
      • 4.6.1 Supporting Political Environment on Embryonic Stem Cell Research will Advance the Stem Cell Industry to Prosper in the United States
      • 4.6.2 Limited Availability of Treatments to Treat Certain Disease Conditions Increases Market Opportunity for Stem Cell Research
    • 4.7 Market Barriers & Challenges
      • 4.7.1 Stem Cell Research and Development is an expensive process which requires considerable funding to be operational
      • 4.7.2 Availability of Adequate Reimbursements are Unclear and leads to a conundrum
      • 4.7.3 Ethical, legal and social issues persists and acts as a challenge
      • 4.7.4 Identifying, recruiting and retaining the best scientific talents is an intractable process for stem cell research based companies
    • 4.8 Stem Cell Research and Development - Market Trends
      • 4.8.1 Booming Stem Cell Tourism is a Potential Opportunity for Countries to Attract Investments
      • 4.8.2 ASLAP Analysis of Stem Cell Tourism
      • 4.8.3 Federal Funding Support Improves the Stem Cell Research Environment
      • 4.8.4 Increasing Entry of Pharmaceutical Companies Boosts Stem Cell Research & Development
      • 4.8.5 PESTLE Analysis
      • 4.8.6 SWOT Analysis of Stem Cell Research & Development
    • 4.9 Industry Analysis
  • 5 Stem Cell Research and Development - Pipeline Analysis
    • 5.1 Pipeline by Various Phases
    • 5.2 Phase III Pipeline Analysis
    • 5.3 Phase II Pipeline Analysis
    • 5.4 Preclinical and Phase 1 Pipeline
  • 6 Stem Cell Research and Development - Investment Trends
    • 6.1 Investor's Perspective on Stem Cell Research
    • 6.2 NIH spending in Stem Cell Research and Development is Increasing and is Supportive
      • 6.2.1 NIH Spending by Stem Cell Research Type
      • 6.2.2 High Budget Projects Funded by NIH
    • 6.3 States Funding on Stem Cell Research in the US is in Reconsideration
    • 6.4 R&D Spending by Stem Cell Research Companies
  • 7 Stem Cell Research and Development - Geographical Trends
    • 7.1 Stem Cell Companies by Geographic Regions
    • 7.2 The United States
    • 7.3 United Kingdom
    • 7.4 China
    • 7.5 Netherlands
    • 7.6 Singapore
    • 7.7 South Korea
    • 7.8 Japan
    • 7.9 India
    • 7.10 Sweden
    • 7.11 Denmark
    • 7.12 France
    • 7.13 Germany
    • 7.14 Israel
    • 7.15 Australia
    • 7.16 Canada
    • 7.17 Czech Republic
  • 8 Stem Cell Research and Development - Mergers and Acquisitions
  • 9 Stem Cell Research and Development - Competitive Structure
    • 9.1 Stem Cell Companies by Therapy Areas
    • 9.2 Stem Cell Companies by Stem Cell Types
  • 10 Stem Cell Research and Development - Company Profiles
    • 10.1 Aastrom Biosciences
    • 10.2 Osiris Therapeutics
    • 10.3 Bioheart
    • 10.4 Aldagen
    • 10.5 Mesoblast
    • 10.6 Geron
    • 10.7 Advanced Cell Technology
    • 10.8 Cytori Therapeutics
    • 10.9 Pluristem Therapeutics
    • 10.10 Medistem
    • 10.11 Neostem
  • 11 Stem Cell Research and Development - Conclusion
  • 12 Appendix
    • 12.1 Market Definitions
    • 12.2 Key Support Data
    • 12.3 Abbreviations
    • 12.4 Methodology
      • 12.4.1 Coverage
      • 12.4.2 Secondary Research
      • 12.4.3 Primary Research
      • 12.4.4 Expert Panels
    • 12.5 Contact Us
    • 12.6 Disclaimer
  • List of Tables
    • Table 1: Disease Conditions and Population in US
    • Table 2: Preferred Countries for Stem Cell Tourism
    • Table 3: Pharmaceutical Companies Partnership Environment
    • Table 4: Phase III Pipeline
    • Table 5: Phase II Pipeline
    • Table 6: Preclinical and Phase 1 Pipelines
    • Table 7: NIH Spending
    • Table 8: Spending of States in US on Stem Cell Research
    • Table 9: Mergers and Acquisitions in Stem Cell Research
    • Table 10: Aastrom Biosciences
    • Table 11: Osiris Therapeutics
    • Table 12: BioHeart
    • Table 13: Aldagen
    • Table 14: Mesoblast
    • Table 15: Geron
    • Table 16: Advanced Cell Technology
    • Table 17: Cytori Therapeutics
    • Table 18: Pluristem Therapeutics
    • Table 19: Medistem
    • Table 20: Neostem
  • List of Figures
    • Figure 1: Stem Cell Research and Development Segmentation
    • Figure 2: Stem Cells - Interaction Framework
    • Figure 3: Cells Models -Present and the Future
    • Figure 4: Unmet Need Vs Time to Market
    • Figure 5: Adult Stem Cells - Applications
    • Figure 6: Technology Adoption Framework
    • Figure 7: Business Models in Stem Cell Industry
    • Figure 8: Political Environnent - Impact Analysis
    • Figure 9: Treatment Availability - Impact Analysis
    • Figure 10: Cost of Research - Impact Analysis
    • Figure 11: Reimbursements - Impact Analysis
    • Figure 12: Ethical, legal and Social Issues - Impact Analysis
    • Figure 13: Human Resources - Impact Analysis
    • Figure 14: ASLAP Analysis of Stem Cell Tourism
    • Figure 15: Stem Cell Research- Federal Funding Trend
    • Figure 16: PESTLE Analysis of Stem Cell Research
    • Figure 17: SWOT Analysis of Stem Cell Research and Development
    • Figure 18: SWOT Analysis of Stem Cell Research and Development - Impact Grid
    • Figure 19: Five Force Analysis
    • Figure 20: Stem Cell Development Pipeline by Clinical Trial Phase
    • Figure 21: VC's Perspective on Stem Cell Research
    • Figure 22: VC's Perspective on Stem Cell Research - Impact Analysis
    • Figure 23: NIH Spending by Stem cell Research Type
    • Figure 24: High Budget Projects Funded by NIH
    • Figure 25: R&D Spending by Public Companies
    • Figure 26: Stem Cell Companies by Geographic Regions
    • Figure 27: Country Analysis - United States
    • Figure 28: Country Analysis - United Kingdom
    • Figure 29: Country Analysis - China
    • Figure 30: Country Analysis - Netherlands
    • Figure 31: Country Analysis - Singapore
    • Figure 32: Country Analysis - South Korea
    • Figure 33: Country Analysis - Japan
    • Figure 34: Country Analysis - India
    • Figure 35: Country Analysis - Sweden
    • Figure 36: Country Analysis - Denmark
    • Figure 37: Country Analysis - France
    • Figure 38: Country Analysis - Germany
    • Figure 39: Country Analysis - Israel
    • Figure 40: Country Analysis - Australia
    • Figure 41: Country Analysis - Canada
    • Figure 42: Country Analysis - Czech Republic
    • Figure 43: Mergers and Acquisitions - Year wise Analysis
    • Figure 44: Stem Cell Companies by Therapy Areas
    • Figure 45: Stem Cell Companies by Stem Cell Types
    • Figure 46: GBI Research Methodology